Immunity for Health

IfH Symposium: Innovations in Antibody-Based Biologics

11 Jun 2026 | Landmark Building, UZ Brussels, Belgium

Biocytogen

Biotech / Medtech / Start-up

biocytogen.com/Waltham, United States
8 profile visits

About

Biocytogen is a global biotech company that drives the discovery of fully human monoclonal, bispecific, multispecific, ADC, VHH, and TCR-mimic antibodies across 1,000+ druggable targets, providing 1M+ antibody sequences through RenBiologics™. Biocytogen pioneers drug target knock-in humanized models and offers 4,000+ models via BioMice™, along with in vivo, ex vivo, and in vitro pharmacology and custom gene-editing services.

Social media

Areas of activity

HEALTH SECTOR

Human health

RESEARCH AND DEVELOPMENT

Preclinical researchCell and Gene therapy

THERAPEUTIC AREAS

OncologyImmunologyAutoimmune disordersRespiratory diseasesAllergiesCardiovascular diseasesNeurodegenerative diseases

Representatives

Business Development Manager

Biocytogen